Integrated Biotherapeutic Vaccines, Inc.

ROCKVILLE, MD · Founded 2019 · CIK 0001882161 · Biotech · Private

Engineered monoclonal antibodies and fusion antibodies with host-cell targeting capabilities

abvacc.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3K
1 Form D · Oct 2021
60 months since last filing
Contracts
—
No federal contracts on record
Patents
3
2 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2680EIGER GROUP INTERNATIONAL, INC.——
2681MOLECULAR WORLD HEALTH, INC.—$5K
2682THINK THERAPEUTICS, INC.——
2683Integrated Biotherapeutic Vaccines, Inc.—$3K
2684Ironfist Therapeutics, Inc.—$2K
2685Eyebiotech Ltd—$486
2686RevOpsis Holdings LLC—$1

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Javad AmanDirector · Executive Officer

Patents

USPTO · 2 granted of 3

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.